SUDDEN UNEXPLAINED JUVENILE DEATH AND THE ROLE OF MEDICOLEGAL

INVESTIGATION: UPDATE ON MOLECULAR AUTOPSY by Argo, A. et al.
SUDDEN UNEXPLAINED JUVENILE DEATH AND THE ROLE OF MEDICOLEGAL  
INVESTIGATION: UPDATE ON MOLECULAR AUTOPSY 
 
Antonina Argo,  Cettina Sortino, Stefania Zerbo, Letizia Averna, Paolo Procaccianti  
Introduction 
Juvenile Sudden Death (SD) has been attracting increasing attention over the past dec-
ades. Heart diseases are the most common cause of an unexpected sudden death in all 
age groups; in young people the main causes include cardiomyopathy, congenital heart 
disease, myocarditis, genetic connective tissue disorders, mitral valve prolapse or con-
duction disease, anomalous coronary arteries (1) and tumors (2). 
In recent years, the contribution of molecular biology assays to the investigation of sud-
den juvenile death has allowed to clarify some of the pathogenetic aspects of arrhythmic 
syndrome-related deaths, enabling preventive actions on the relatives of the deceased 
patients (3). 
The adoption of standardized survey protocols, not yet sufficiently implemented in foren-
sic practice, could lead to an increased identification of the cause of death, and eventu-
ally to the application of the relevant morphological and genetic analysis in family mem-
bers. For this reason, it is important to encourage the propensity of the scientific and 
clinical communities to create links between clinicians and forensic and molecular investi-
gators. 
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SUMMARY 
In the past few years, contributions of molecular biology assays to the investigation of 
sudden juvenile death have permitted to clarify some of the pathogenetic aspects of sud-
den arrhythmic death, opening the way to preventive action on victims’ relatives. 
We reviewed literature on the genetics of sudden juvenile death, and on molecular biol-
ogy assays performed on autoptic samples.  
Biological investigation permits the detection of genetic mutations underlying the suscep-
tibility to sudden cardiac death of individuals with rare inherited forms of arrhythmia 
(Long QT Syndrome,  Brugada Syndrome, Lev’s disease etc.) through the analysis of criti-
cal sequences codifying for ion channel subunits (HERG, KvLQT1, MinK, Mirp1, SCN5A, 
KCNQ1, KCNH2, KCNE1, KCNE2).  
The main objective of post-mortem investigation in sudden juvenile death is the detection 
of treatable monogenic inherited disorders, in order to prevent further deaths among the 
relatives of the deceased patient. 
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Material and method     
We reviewed literature on the genetics of 
sudden juvenile death and on molecular 
biology assays performed on autoptic 
samples, in order to define an appropriate 
methodology.  
Results 
Sudden death in young people (1-35 years 
of age) is currently described as a sudden 
natural death occurring within one hour 
from the onset of new symptoms (4). 
Most of the recent progresses in the autop-
tic diagnosis of sudden unexpected death 
in adults originate from molecular biology, 
especially in cases of sudden death without 
significant morphological anomalies. De-
tection of mutations linked with functional 
cardiac pathologies, such as long-QT syn-
drome, Brugada syndrome or idiopathic 
ventricular fibrillation, is now considered 
the first step in finding the cause for such 
sudden death. 
Molecular investigation is necessary to 
identify the genetic mutations underlying 
sudden cardiac death susceptibility in 
individuals with rare hereditary arrhythmic 
diseases (such as long QT syndrome, Bru-
gada syndrome, Lev's disease, etc.). Sev-
eral laboratories have identified mutations 
in genes that encode cardiac ion channels 
(for example HERG, KvLQT1, Mink, Mirp1 
and SCN5A) that underlie channelopathies 
(4). 
Approximately 50-60% of LQTS is caused 
by a mutation in one of the several genes 
that affect the structure or function of ion 
channels: KCNQ1, KCNH2, SCN5A, KCNE1 
and KCNE2 (5). 
Morita and colleagues studied 84 children 
with idiopathic cardiac hypertrophy diag-
nosed before 15 years of age, by sequenc-
ing the genes MYH7, MYBPC3, TNNT2, 
TNNI3, TPM1, MYL3, MYL2 and ACTC that 
encode for sarcomeric proteins that, if 
mutated, cause adult-onset cardio-
myopathies, and the PRKAG2 and LAMP2 
genes that code for proteins and metabo-
lites whose mutations cause early-onset 
ventricular hypertrophy (6). 
Hypertrophic cardiomyopathy is the main 
cause of sudden death in young athletes, 
and it has been associated with mutations 
in genes that encode sarcomeric proteins 
(tropomyosin, troponin T and I, and actin). 
Recently, new mutations have also been 
identified in the gene that encodes tro-
ponin C (TNNC1: A8V, C84Y, E134D and 
D145E) (7). 
The screening protocol preceding athletic 
competitions, launched in Italy in 1982 for 
the prevention of sudden death in young 
athletes, provided surprising results with 
the annual incidence of sudden death de-
creasing by 89%, mainly due to the decline 
in mortality of athletes with cardio-
myopathies (8). 
 
Discussion 
Sudden juvenile death is a devastating 
event for both the family and the commu-
nity. Over the last decade, significant ad-
vances have been made in understanding 
the clinical and genetic basis of sudden 
cardiac death in the youth. Many cases of 
sudden death in young people are related 
to genetic heart disorders, which can lead 
to both structural (e.g. hypertrophic car-
diomyopathy) and arrhythmogenic (e.g. 
familial long QT syndrome) abnormalities. 
Commonly, the sudden cardiac death of a 
young person can be the first presentation 
of an underlying heart problem, leaving 
the family without a reason for why an 
otherwise healthy young person died 
(figure 1). Not only is this a tragic event for 
everyone involved, but it also presents a 
medical challenge to the clinician(s) in-
volved in the management of the surviving 
family members. The molecular biology 
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Figure 1: Haemangioma in the apex of 
the heart 
approach contributes to the etiopathoge-
netic definition of the early onset of idio-
pathic cardiac hypertrophy (mutations in 
MYH7 and MYBPC3), and of cardiac hyper-
trophy associated with sudden death in 
young athletes (mutations in the genes 
codifying for tropomyosin, troponin T and 
I, actin, and troponin C). 
Evaluation of remaining family members 
requires a multidisciplinary approach that 
should include cardiologists, a clinical 
geneticist, a genetic counsellor and a fo-
rensic pathologist directly involved in the 
sudden death case. Therefore, genetic 
analyses (molecular autopsies) are becom-
ing a useful tool in forensic medicine, 
allowing the identification and prevention 
of the causes of sudden cardiac death, as 
well as improving the chances of an early 
diagnosis of asymptomatic carriers among 
relatives. 
 
Conclusion 
This article briefly outlines the current 
understanding of the role of genetics in 
sudden cardiac death. Furthermore, it also 
highlights the fact that the molecular biol-
ogy approach contributes to the etiopatho-
genetic definition of the early onset of 
idiopathic cardiac hypertrophy (mutations 
in MYH7 and MYBPC3), and of cardiac 
hypertrophy associated with sudden death 
in young athletes (mutations in the genes 
codifying for tropomyosin, troponin T and 
I, actin and troponin C). Performing rele-
vant molecular assays on autoptic samples 
(“molecular autopsy”) is technically feasible 
and allows the execution of clinical-genetic 
investigations oriented towards preventa-
tive measures among the relatives of the 
deceased patient. 
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